A new innovation for drug delivery and mucosal protection in patients with OSMF

Abstract

Oral submucous fibrosis is a chronic, debilitating disease characterized by gradually increasing fibrosis of oral cavity and pharynx, mainly the buccal mucosa, resulting in trismus. Various flaps have been used to reconstruct the surgical defects following excision of fibrous bands. It is inevitable to prevent these flaps from trauma by occlusion. The main objective of this technical innovation is to protect the flaps in the post-operative period, prevent injury to buccal mucsa which is quiet stiff and also deliver drug over prolonged period of time.